Weight loss jabs like Wegovy combat several diverse conditions, from heart attacks to cancer, and the explanation may be that they stop inflammation ...

At a press event on Monday, announced a sweeping executive order aimed at slashing prescription drug prices in the US.

A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...

The popularity of expensive weight-loss medications and other prescription drugs along with higher hospital costs are driving ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

Both the Mounjaro and Wegovy jabs used in the trial were found to be effective treatments for patients with obesity, but one ...

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...